Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development.

Abstract excerpt

Pulmonary arterial hypertension (PAH), at one time a largely overlooked disease, is now the subject of intense study in many academic and biotech groups. The availability of new treatments has increased awareness of the condition. This in turn has driven a change in the demographics of PAH, with an increase in the mean age at diagnosis. The diagnosis of PAH in more elderly patients has highlighted the need for...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomarkers
• Share to BMPR2 gene
• Share to PAH gene